• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012015-150
Device Problems Stretched (1601); Malposition of Device (2616); Mechanical Jam (2983); Activation Failure (3270)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/10/2020
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints reported from this lot.The investigation determined that the reported difficulties and subsequent treatment were likely due to case circumstances.It is likely that the distal shaft was bent or restricted in the anatomy (possibly at the aortic bifurcation which was reported to be extremely calcified) preventing the shaft lumens from moving freely and preventing the thumbwheel from rotating.The additional reported difficulties of the stent stretching, and malposition of the stent was likely the result of manipulation to the delivery system in order to manually deploy the stent.The additional treatment and foreign body in patient were related to case circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
It was reported that the procedure was performed to treat a de novo lesion with heavy calcification, moderate tortuosity, and 75% stenosis in the mid to distal left superior femoral artery (sfa).A non-abbott guide wire was placed and pre-dilatation was performed with a 4.0 x 80 mm armada 35 balloon.A non-abbott 6fr sheath was also placed from the contralateral groin.The aortic bifurcation was extremely calcified so the sheath could only just be advanced into the left common iliac artery.A 6.0x150 mm absolute pro self-expanding stent system was then advanced; however, on deployment of the stent, the thumbwheel stopped turning and the stent could only be partially deployed.The stent handle was broken apart to expose the inner mechanism and the stent was able to be deployed in something like a "pin/pull" fashion.This resulted in elongation of the stent and the stent being deployed in the proximal left common iliac artery instead of mid to distal left superficial artery (sfa) which was the location of the target lesion.The elongated stent was dilated with a 6.0 x 150 mm armada balloon, and flow was maintained throughout the stented segment.The physician suspected that the issue was the sheath was not over far enough and the calcification stopped the sheath from retracting and preventing the thumbwheel to roll.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Event Description
Subsequent to the original filing, on may 11th, 2022, abbott determined that a field safety notice was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Manufacturer Narrative
Although the difficulties encountered appear to be related to procedural circumstances, on may 11th, 2022, abbott determined that a field safety notice (fsn) was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key10897182
MDR Text Key218940780
Report Number2024168-2020-09867
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup
Report Date 06/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2023
Device Catalogue Number1012015-150
Device Lot Number0032462
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE WIRE: 260CM ZIPWIRE BOSTON SCIENTIFIC.; INTRODUCER SHEATH: 6FR ANL.
Patient Outcome(s) Required Intervention;
-
-